Company intelligence / Profile preview

Woodside Way Ventures

Ownership: Private
Development stage: Other

Overview

Woodside Way Ventures is an active venture capital firm focused on investing in early-stage biotechnology and life science companies. The firm’s leadership includes Dr. Robert Sikorski, who brings significant experience from both large biopharma and startup environments. The fund provides strategic guidance and capital to emerging health innovation ventures but does not itself develop therapeutics or diagnostics.

Modalities: Small moleculeMonoclonal antibodyCell therapy
Industry: Investors

Beyond the preview

Go deeper on Woodside Way Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Woodside Way Ventures.

Explore the full profile